Mise au point dans la prise en charge respiratoire des maladies neuromusculaires chroniques

Priou, Pascaline; Trzépizur, Wojciech; Meslier, Nicole; Gagnadoux, Frédéric

doi:10.1016/j.pneumo.2017.10.001

Cited by 6 publications

(2 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In patients affected by NMDs, respiratory impairment is common and includes inspiratory and expiratory muscle weakness, ineffective cough, alteration of blood gases, nocturnal sleep disorder, reduction of vital capacity, and dyspnea during activities of daily living (ADLs), strongly contributing to progressive disability (14,15). Therefore, this population is at higher risk of recurrent lower respiratory tract infections and acute respiratory failure that increase hospitalization and mortality rates (16).…”

Section: Covid-19 and Respiratory Involvement In Nmdsmentioning

confidence: 99%

Rehabilitation of Neuromuscular Diseases During COVID-19: Pitfalls and Opportunities

et al. 2021

View full text Add to dashboard Cite

The outbreak of COVID-19 caused by SARS-CoV-2 has spread worldwide with a huge impact on the healthcare system. Compared to the previous coronaviruses-related pandemics, COVID-19 is more transmissible with potential systemic involvement and peculiar neurological manifestations, such as Guillan-Barrè syndrome up to critical illness myopathy, occurring in the intensive care setting. In this clinical scenario, people living with a neuromuscular disease (NMD) represent a vulnerable category with a high risk of a severe course of COVID-19. Moreover, in the NMD population, the management of respiratory and muscular impairments after SARS-CoV-2 infection might be troubling in terms of both pharmacological and rehabilitative approaches. To date, rehabilitation is still an unmet need in this population with several implications on NMD progression with and without SARS-CoV-2 infection. In particular, rehabilitation intervention for patients with NMD after COVID-19 are lacking. Therefore, in the current paper, we analyze the critical issues of COVID-19 on NMDs patients and propose a home-based rehabilitation program targeted for this population after mild to moderate SARS-CoV-2 infection.

show abstract

Section: Covid-19 and Respiratory Involvement In Nmdsmentioning

confidence: 99%

Rehabilitation of Neuromuscular Diseases During COVID-19: Pitfalls and Opportunities

et al. 2021

View full text Add to dashboard Cite

show abstract

“…A peak PaCO2 during sleep measured by transcutaneous sensor (TcCO2) above 49 mmHg is considered as a major criterion to start ventilatory support in NMD patients. [1] Nocturnal ventilatory support is generally offered via a nasal mask [2], but one third of patient with NMDs require oronasal masks [3]. Clear indicators with regards to the progression of nocturnal ventilation into the daytime are not available.…”

Section: Introductionmentioning

confidence: 99%

Mouthpiece ventilation in neuromuscular disorders: Narrative review of technical issues important for clinical success

Toussaint¹,

Chatwin²,

Gonçalves³

et al. 2021

Respiratory Medicine

View full text Add to dashboard Cite

reported general guidelines for management of daytime MPV in NMDs. This report could not present all the detail regarding the technical issues important for clinical success of MPV. Based on the expert workshop discussions and the evidence from existing studies, the current narrative review aims to identify the technical issues of MPV and offers guidance via a decisional algorithm and educational figures providing relevant information that is important for successful implementation of MPV.

show abstract

French National Protocol for diagnosis and care of facioscapulohumeral muscular dystrophy (FSHD)

Attarian,

Beloribi-Djefaflia,

Bernard

et al. 2024

J Neurol

View full text Add to dashboard Cite

Mise au point dans la prise en charge respiratoire des maladies neuromusculaires chroniques

Cited by 6 publications

References 37 publications

Rehabilitation of Neuromuscular Diseases During COVID-19: Pitfalls and Opportunities

Rehabilitation of Neuromuscular Diseases During COVID-19: Pitfalls and Opportunities

Mouthpiece ventilation in neuromuscular disorders: Narrative review of technical issues important for clinical success

French National Protocol for diagnosis and care of facioscapulohumeral muscular dystrophy (FSHD)

Contact Info

Product

Resources

About